CUEDC2 and central nervous system cancer: Brain Cytoplasmic RNA 1 (BCYRN1) binding with miR-619-5p can regulate CUE Domain Containing 2 (CUEDC2) expression and the PTEN/AKT/p21 pathway to inhibit glioma tumorigenesis [8].